AEP
45
5
ROST
60
3
TGT
35
4
LMT
29
-5
BEN
36
4
THC
52
9
AMGN
42
14
AAL
56
5
UHS
50
4
AEE
51
3
DGX
28
4
DRI
74
5
ABT
54
4
SLB
41
2
EMN
40
5
PNW
55
3
HPE
48
2
BF.B
35
2
HAL
40
11
MTB
38
4
AEP
45
5
ROST
60
3
TGT
35
4
LMT
29
-5
BEN
36
4
THC
52
9
AMGN
42
14
AAL
56
5
UHS
50
4
AEE
51
3
DGX
28
4
DRI
74
5
ABT
54
4
SLB
41
2
EMN
40
5
PNW
55
3
HPE
48
2
BF.B
35
2
HAL
40
11
MTB
38
4
Financhill
Back

Antofagasta PLC 10K Form

Buy
52

ANFGF
Antofagasta PLC

Last Price:
$20.89
Seasonality Move:
8.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ANFGF News And Ratings

See the #1 stock for the next 7 days that we like better than ANFGF

ANFGF Financial Statistics

Sales & Book Value

Annual Sales: $6.3B
Cash Flow: $0
Price / Cash Flow: 68.47
Annual Sales: $9.12
Price / Book: 2.29

Profitability

EPS (TTM): 0.77500
Net Income (TTM): $764.3M
Gross Margin: $2.7B
Return on Equity: 6.37%
Return on Assets: 3.86%

Antofagasta PLC Earnings Forecast

Key Antofagasta PLC Financial Ratios

  • The Gross Profit Margin over the past 19 years for ANFGF is 42.03%.
  • The Selling, General & Administrative Expenses for ANFGF have been equal to 9.78% of Gross Profit Margin.
  • The Research & Development expenses have been 2.16% of Revenue.
  • The Interest Expense is 14.54% of Operating Income.
  • The Net Earning history of ANFGF is 13.20% of Total Revenues.
  • Per Share Earnings over the last 39 years have been positive in 23 years.

Antofagasta PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Metals & Mining
Sector: Materials
Current Symbol: ANFGF
Website: antofagasta.co.uk

Debt

Debt-to-Equity Ratio: 0.56
Current Ratio: 2.14
Quick Ratio: 1.83

Price-to-Earnings

Trailing P/E Ratio: 24.66
Forward P/E Ratio: 0

ANFGF Technical Analysis vs Fundamental Analysis

Buy
52
Antofagasta PLC (ANFGF) is a Buy

Is Antofagasta PLC a Buy or a Sell?

  • Antofagasta PLC stock is rated a Buy
    The current Antofagasta PLC [ANFGF] share price is $20.89. The Score for ANFGF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.